These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

235 related items for PubMed ID: 20931557

  • 1. Inhibition of hepatitis C virus replication using adeno-associated virus vector delivery of an exogenous anti-hepatitis C virus microRNA cluster.
    Yang X, Haurigot V, Zhou S, Luo G, Couto LB.
    Hepatology; 2010 Dec; 52(6):1877-87. PubMed ID: 20931557
    [Abstract] [Full Text] [Related]

  • 2. Preclinical evaluation of an anti-HCV miRNA cluster for treatment of HCV infection.
    Yang X, Marcucci K, Anguela X, Couto LB.
    Mol Ther; 2013 Mar; 21(3):588-601. PubMed ID: 23295950
    [Abstract] [Full Text] [Related]

  • 3. Alleviation of off-target effects from vector-encoded shRNAs via codelivered RNA decoys.
    Mockenhaupt S, Grosse S, Rupp D, Bartenschlager R, Grimm D.
    Proc Natl Acad Sci U S A; 2015 Jul 28; 112(30):E4007-16. PubMed ID: 26170322
    [Abstract] [Full Text] [Related]

  • 4. Transduction with Lentiviral Vectors Altered the Expression Profile of Host MicroRNAs.
    Huang H, Zhang C, Wang B, Wang F, Pei B, Cheng C, Yang W, Zhao Z.
    J Virol; 2018 Sep 15; 92(18):. PubMed ID: 29997205
    [Abstract] [Full Text] [Related]

  • 5. Successful disabling of the 5' UTR of HCV using adeno-associated viral vectors to deliver modular multimeric primary microRNA mimics.
    Bourhill T, Arbuthnot P, Ely A.
    J Virol Methods; 2016 Sep 15; 235():26-33. PubMed ID: 27181212
    [Abstract] [Full Text] [Related]

  • 6. Expression of Duplex shRNAs through a Lentiviral Vector against Cellular and Viral Genes Inflicts Sustained Inhibition of Hepatitis C Virus Replication.
    Mandal A, Chaubey B.
    Intervirology; 2018 Sep 15; 61(2):79-91. PubMed ID: 30253401
    [Abstract] [Full Text] [Related]

  • 7. Downregulation of hepatitis C virus replication by miR-196a using lentiviral vectors.
    Shafaati M, Jamalidoust M, Kargar M, Arefian E, Kafilzadeh F.
    Microbiol Immunol; 2021 Apr 15; 65(4):161-170. PubMed ID: 33470443
    [Abstract] [Full Text] [Related]

  • 8. In vitro characterization of the activity of PF-05095808, a novel biological agent for hepatitis C virus therapy.
    Lavender H, Brady K, Burden F, Delpuech-Adams O, Denise H, Palmer A, Perkins H, Savic B, Scott S, Smith-Burchnell C, Troke P, Wright JF, Suhy D, Corbau R.
    Antimicrob Agents Chemother; 2012 Mar 15; 56(3):1364-75. PubMed ID: 22203606
    [Abstract] [Full Text] [Related]

  • 9. RNA interference inhibitors of hepatitis B virus.
    McCaffrey AP.
    Ann N Y Acad Sci; 2009 Sep 15; 1175():15-23. PubMed ID: 19796073
    [Abstract] [Full Text] [Related]

  • 10. Development of gene therapy for treatment of age-related macular degeneration.
    Askou AL.
    Acta Ophthalmol; 2014 Jul 15; 92 Thesis3():1-38. PubMed ID: 24953666
    [Abstract] [Full Text] [Related]

  • 11. Safe, long-term hepatic expression of anti-HCV shRNA in a nonhuman primate model.
    Suhy DA, Kao SC, Mao T, Whiteley L, Denise H, Souberbielle B, Burdick AD, Hayes K, Wright JF, Lavender H, Roelvink P, Kolykhalov A, Brady K, Moschos SA, Hauck B, Zelenaia O, Zhou S, Scribner C, High KA, Renison SH, Corbau R.
    Mol Ther; 2012 Sep 15; 20(9):1737-49. PubMed ID: 22735378
    [Abstract] [Full Text] [Related]

  • 12. Inhibition of HCV replication by small interfering RNA.
    Ray RB, Kanda T.
    Methods Mol Biol; 2009 Sep 15; 510():251-62. PubMed ID: 19009267
    [Abstract] [Full Text] [Related]

  • 13. A multiplexed miRNA and transgene expression platform for simultaneous repression and expression of protein coding sequences.
    Seyhan AA.
    Mol Biosyst; 2016 Jan 15; 12(1):295-312. PubMed ID: 26617199
    [Abstract] [Full Text] [Related]

  • 14. Hepatic cell-to-cell transmission of small silencing RNA can extend the therapeutic reach of RNA interference (RNAi).
    Pan Q, Ramakrishnaiah V, Henry S, Fouraschen S, de Ruiter PE, Kwekkeboom J, Tilanus HW, Janssen HL, van der Laan LJ.
    Gut; 2012 Sep 15; 61(9):1330-9. PubMed ID: 22198713
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Simultaneous targeting of HCV replication and viral binding with a single lentiviral vector containing multiple RNA interference expression cassettes.
    Henry SD, van der Wegen P, Metselaar HJ, Tilanus HW, Scholte BJ, van der Laan LJ.
    Mol Ther; 2006 Oct 15; 14(4):485-93. PubMed ID: 16872906
    [Abstract] [Full Text] [Related]

  • 17. Hairpin ribozymes in combination with siRNAs against highly conserved hepatitis C virus sequence inhibit RNA replication and protein translation from hepatitis C virus subgenomic replicons.
    Jarczak D, Korf M, Beger C, Manns MP, Krüger M.
    FEBS J; 2005 Nov 15; 272(22):5910-22. PubMed ID: 16279954
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Recombinant AAV as a platform for translating the therapeutic potential of RNA interference.
    Borel F, Kay MA, Mueller C.
    Mol Ther; 2014 Apr 15; 22(4):692-701. PubMed ID: 24352214
    [Abstract] [Full Text] [Related]

  • 20. Disturbance of the microRNA pathway by commonly used lentiviral shRNA libraries limits the application for screening host factors involved in hepatitis C virus infection.
    Pan Q, de Ruiter PE, von Eije KJ, Smits R, Kwekkeboom J, Tilanus HW, Berkhout B, Janssen HL, van der Laan LJ.
    FEBS Lett; 2011 Apr 06; 585(7):1025-30. PubMed ID: 21376045
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.